Results 11 to 20 of about 122,056 (334)

MYSTIC: Michigan Young STar Imager at CHARA [PDF]

Astronomical Telescopes + Instrumentation, 2018
We present the design for MYSTIC, the Michigan Young STar Imager at CHARA. MYSTIC will be a K-band, cryogenic, 6-beam combiner for the Georgia State University CHARA telescope array.
Anugu, Narsireddy, Bouquin, Jean-Baptiste Le, Brummelaar, Theo ten, Ennis, Jacob, Jocou, Laurent, Kraus, Stefan, Lanthermann, Cyprien, Monnier, John D., Setterholm, Benjamin R.   +8 more
core   +4 more sources

Testing the Mystic School Mobile Application to Promote Active Commuting to School in Spanish Adolescents: The PACO Study. [PDF]

Children (Basel), 2022
Active commuting to and/or from school (ACS) is an opportunity to increase daily physical activity (PA) levels in young people. Mobile-device interventions focused on promoting the practice of health-related PA can be more cost-effective than traditional
Saucedo-Araujo RG, Huertas-Delgado FJ, Barranco-Ruiz YM, Pérez-López IJ, Aznar-Laín S, Chillón P, Herrador-Colmenero M.   +6 more
europepmc   +2 more sources

MYSTIC: a high angular resolution K-band imager at CHARA

Astronomical Telescopes + Instrumentation, 2022
The Michigan Young STar Imager at CHARA (MYSTIC) is a K-band interferometric beam combining instrument funded by the United States National Science Foundation, designed primarily for imaging sub-au scale disk structures around nearby young stars and to ...
B. Setterholm, J. Monnier, J. Le Bouquin, N. Anugu, J. Ennis, B. Flores, T. Gardner, Nour Ibrahim, L. Jocou, S. Kraus, C. Lanthermann, G. Schaefer, T. T. ten Brummelaar   +12 more
semanticscholar   +1 more source

A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: The MYSTIC study.

The ocular surface, 2021
PURPOSE Dry eye disease is characterized by loss of tear film stability. OC-01 (varenicline solution) is a small-molecule nicotinic acetylcholine receptor agonist administered as a nasal spray that stimulates tear production.
H. Quiroz-Mercado, E. Hernández-Quintela, Kuei-Hsun Chiu, E. Henry, J. Nau   +4 more
semanticscholar   +1 more source

Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC).

Clinical Lung Cancer, 2021
BACKGROUND The phase 3 MYSTIC study of durvalumab ± tremelimumab versus chemotherapy in metastatic non-small-cell lung cancer (NSCLC) patients with tumor cell (TC) programmed cell death ligand 1 (PD-L1) expression ≥ 25% did not meet its primary endpoints.
E. Garon, B. Cho, N. Reinmuth, K. Lee, A. Luft, M. Ahn, G. Robinet, S. Le Moulec, R. Natale, J. Schneider, F. Shepherd, M. Garassino, Sarayut Lucien Geater, Zsolt Pápai Székely, T. Van Ngoc, Feng Liu, U. Scheuring, N. Patel, S. Peters, N. Rizvi   +19 more
semanticscholar   +1 more source

A Mystic Weed, Parthenium hysterophorus: Threats, Potentials and Management

Agronomy, 2021
Parthenium hysterophorus is an invasive weed species that competes aggressively with other plants and is also allelopathic. It poses a significant risk to human health, livestock, the environment, soil, and agriculture.
H. Bashar, A. Juraimi, M. S. Ahmad-Hamdani, M. Uddin, N. Asib, Md. Parvez Anwar, F. Rahaman   +6 more
semanticscholar   +1 more source

Microvascular dysfunction in COVID-19: the MYSTIC study

Angiogenesis, 2020
Rationale Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19.
Alexandros Rovas, Irina Osiaevi, Konrad Buscher, J. Sackarnd, Phil Tepasse, M. Fobker, J. Kühn, Stephan Braune, Ulrich Göbel, G. Thölking, A. Gröschel, H. Pavenstädt, H. Vink, P. Kümpers   +13 more
semanticscholar   +1 more source

A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study

Clinical Cancer Research, 2020
Purpose: Tumor mutational burden (TMB) has been shown to be predictive of survival benefit in patients with non–small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors.
Han Si, M. Kuziora, K. Quinn, E. Helman, Jiabu Ye, Feng Liu, U. Scheuring, S. Peters, N. Rizvi, P. Brohawn, K. Ranade, B. Higgs, K. Banks, V. Chand, R. Raja   +14 more
semanticscholar   +1 more source

The God of Julian of Norwich: A Christological reading in a follow-up key

Verbum et Ecclesia, 2023
This article presents some of the results of the research on the God that Julian of Norwich makes known to us through her Christological revelations. This woman left a writing about her revelations, in which Jesus Christ is the centre of her theology. In
Edith Gonzalez-Bernal
doaj   +1 more source

Makna Relijius Dalam Ritual Adat Masyarakat Pesisir Kabupaten Gunungkidul

Ulumuddin, 2021
The Rasulan tradition is synonymous with the coastal communities of Gunungkidul. This tradition is used as a means of worship and offerings to spirits, the spirits of the ancestors of the gods and the rulers of the universe.
Heri Kuswanto, Ricy Fatkhurrokhman, Khoirul Anam   +2 more
doaj   +1 more source